Gene expression profiling in early breast cancer treated with neoadjuvant ribociclib plus letrozole (R+L) versus chemotherapy (CT): A correlative analysis of the SOLTI-1402/CORALLEEN phase II trial
G. Griguolo1, G. Serna2, T. Pascual3, R. Fasani2, N. Chic4, L. Paré5, S. Pernas6, M. Muñoz4, A.M. Antunes De Melo e Oliveira7, M. Vidal4, A. Llombart Cussac8, J. Cortés9, P. Galván4, B. Bermejo10, N. Martínez11, R. López12, S. Morales13, P. Villagrasa5, A. Prat14, P. Nuciforo2
Communication in congress
ePoster
ESMO BREAST
2020
